Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Cardiotoxicity of doxorubicin (DOX) remains an important health concern. DOX cardiotoxicity is cumulative-dose-dependent and begins with the first dose of chemotherapy. No biomarker for presymptomatic detection of DOX cardiotoxicity has been validated. Our hypothesis is that peripheral blood cells (...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorova, Valentina K., Makhoul, Issam, Siegel, Eric R., Wei, Jeanne, Stone, Annjanette, Carter, Weleetka, Beggs, Marjorie L., Owen, Aaron, Klimberg, V. Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973957/
https://www.ncbi.nlm.nih.gov/pubmed/27490685
http://dx.doi.org/10.1371/journal.pone.0160224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973957/
https://www.ncbi.nlm.nih.gov/pubmed/27490685
http://dx.doi.org/10.1371/journal.pone.0160224

Ejemplares similares